Biomeva: AGC acquires Biomeva
Biomeva a CMO in the biopharmaceutical industry is dedicated to meeting the manufacturing needs for the production of microbially expressed protein products. The post AGC acquires Biomeva appeared first on PharmaAsia.
Read full article »
CEO
Thomas Pultar
Biomeva is a contract manufacturing organization that offers cell banking and GMP production for protein therapeutics.
Read more